UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The global health burden of hepatitis C virus infection

Liver international, 2011-07, Vol.31 (s2), p.1-3

2011

Volltextzugriff (PDF)

Increased incidence of liver cancer after successful DAA treatment of chronic hepatitis C: Fact or fiction?

Liver international, 2017-06, Vol.37 (6), p.802-808

2017

Volltextzugriff (PDF)

Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy

World journal of gastroenterology : WJG, 2006-06, Vol.12 (23), p.3682

2006

Volltextzugriff (PDF)

Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C

Journal of hepatology, 2010-02, Vol.52 (2), p.191-198

2010

Volltextzugriff (PDF)

Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study

Journal of hepatology, 2010-10, Vol.53 (4), p.630-638

2010

Volltextzugriff (PDF)

Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B

World journal of gastroenterology : WJG, 2007-01, Vol.13 (4), p.525

2007

Volltextzugriff (PDF)

Estimated prevalence of undiagnosed HCV infected individuals in Italy: A mathematical model by route of transmission and fibrosis progression

Epidemics, 2021-03, Vol.34, p.100442-100442, Article 100442

2021

Volltextzugriff (PDF)

A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regions

BMC infectious diseases, 2022-01, Vol.22 (1), p.58-58, Article 58

2022

Volltextzugriff (PDF)

Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C

Journal of hepatology, 2006-04, Vol.44 (4), p.686-693

2006

Volltextzugriff (PDF)

SHORT STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTS

Journal of hepatology, 2005-05, Vol.42 (5), p.615-624

2005

Volltextzugriff (PDF)

Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy： Potential role of insulin

World journal of gastroenterology : WJG, 2008-10, Vol.14 (37), p.5695-5700

2008

Volltextzugriff (PDF)

Hyperinsulinemia Promotes Esophageal Cancer Development in a Surgically-Induced Duodeno-Esophageal Reflux Murine Model

International journal of molecular sciences, 2018-04, Vol.19 (4), p.1198

2018

Volltextzugriff (PDF)

Liver Microsomal Triglyceride Transfer Protein Is Involved in Hepatitis C Liver Steatosis

Gastroenterology (New York, N.Y. 1943), 2006-05, Vol.130 (6), p.1661-1669

2006

Volltextzugriff (PDF)

Effect of peginterferon alfa‐2a on liver histology in chronic hepatitis C: A meta‐analysis of individual patient data

Hepatology (Baltimore, Md.), 2004-02, Vol.39 (2), p.333-342

2004

Volltextzugriff (PDF)

Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study

Hepatology (Baltimore, Md.), 2002-10, Vol.36 (4), p.973-977

2002

Volltextzugriff (PDF)

Non-invasive evaluation of liver fibrosis using transient elastography

Journal of hepatology, 2008-05, Vol.48 (5), p.835-847

2008

Volltextzugriff (PDF)

Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP)

Nutrition & metabolism, 2010-02, Vol.7 (1), p.13-13, Article 13

2010

Volltextzugriff (PDF)

Impact of a sustained virological response on the long-term outcome of hepatitis C

Liver international, 2011-01, Vol.31 (s1), p.18-22

Alberti, Alfredo

2011

Volltextzugriff (PDF)

For a program of eradication of hepatitis C in the populations at risk (drug users and convicts)

Acta bio-medica de l'Ateneo Parmense, 2018-01, Vol.89 (Suppl 10), p.33-41

2018

Volltextzugriff (PDF)

What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?

Liver international, 2009-01, Vol.29 (s1), p.15-18

Alberti, Alfredo

2009

Volltextzugriff (PDF)

The evolution of the therapeutic strategy in hepatitis C: Features of sofosbuvir and indications

Digestive and liver disease, 2014-12, Vol.46, p.S174-S178

2014

Volltextzugriff (PDF)

Budget impact analysis of the use of daclatasvir in Italy for the treatment of Hepatitis C Virus (HCV) genotype 3 patients

Farmeconomia. Health economics and therapeutic pathways, 2016-03, Vol.17 (1), p.7-12

2016

Volltextzugriff (PDF)

Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study

Journal of hepatology, 2018-08, Vol.69 (2), p.345-352

2018

Volltextzugriff (PDF)

Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels

Journal of hepatology, 2005-02, Vol.42 (2), p.266-274

Alberti, Alfredo

2005

Volltextzugriff (PDF)

1 – 25 von 346

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(305)
Mit Volltextzugriff
(284)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The global health burden of hepatitis C virus infection

Increased incidence of liver cancer after successful DAA treatment of chronic hepatitis C: Fact or fiction?

Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy

Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C

Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study

Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

Estimated prevalence of undiagnosed HCV infected individuals in Italy: A mathematical model by route of transmission and fibrosis progression

A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regions

Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C

SHORT STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTS

Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy： Potential role of insulin

Hyperinsulinemia Promotes Esophageal Cancer Development in a Surgically-Induced Duodeno-Esophageal Reflux Murine Model

Liver Microsomal Triglyceride Transfer Protein Is Involved in Hepatitis C Liver Steatosis

Effect of peginterferon alfa‐2a on liver histology in chronic hepatitis C: A meta‐analysis of individual patient data

Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study

Non-invasive evaluation of liver fibrosis using transient elastography

Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP)

Impact of a sustained virological response on the long-term outcome of hepatitis C

For a program of eradication of hepatitis C in the populations at risk (drug users and convicts)

What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?

The evolution of the therapeutic strategy in hepatitis C: Features of sofosbuvir and indications

Budget impact analysis of the use of daclatasvir in Italy for the treatment of Hepatitis C Virus (HCV) genotype 3 patients

Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study

Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels

Suchergebnisse filtern